Purification and characterization, of the human PDE4A catalytic domain (PDE4A330-723) expressed in Sf9 cells

被引:9
作者
Lario, PL
Bobechko, B
Bateman, K
Kelly, J
Vrielink, A
Huang, Z
机构
[1] Merck Frosst Ctr Therapeut Res, Pointe Claire, PQ H9R 4P8, Canada
[2] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada
关键词
PDE4; cAMP; Erk2; phosphorylation; PDE4A; cofactor; CDP-840; IBMX; KF-18280; rolipram; SB-207499; PAINPQ;
D O I
10.1006/abbi.2001.2513
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human PDE4A catalytic domain (PDE4A(330-723)) expressed in Sf9 cells was found to be heavily phosphorylated on both serines of the conserved SPS motif by mass spectrometric analysis. The purified protein exists as a tetramer at a concentration similar to1 mg/ml from light scattering measurement and has a K-m of 2 muM in hydrolyzing cAMP. In comparison, a partially purified PDE4A(330-723) expressed in Escherichia coli has an apparent K-m of 10 muM The EC50 values for the Mg2+- or Co2+-mediated cAMP hydrolysis between the two enzymes differed by less than twofold. In addition, both enzymes exhibit similar sensitivities toward inhibition by a diverse set of inhibitors. Together with the fact that its adjacent peptide was covalently labeled by an electrophilic cAMP analogue, these results support that the SPS motif is not part of but is positioned near the active site. An efficient purification protocol that provides a highly purified PDE4A catalytic domain suitable for crystallization study is described. (C) 2001 Academic Press.
引用
收藏
页码:54 / 60
页数:7
相关论文
共 26 条
[1]   Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases [J].
Baillie, GS ;
MacKenzie, SJ ;
McPhee, I ;
Houslay, MD .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (04) :811-819
[2]   UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions [J].
Beard, MB ;
Olsen, AE ;
Jones, RE ;
Erdogan, S ;
Houslay, MD ;
Bolger, GB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) :10349-10358
[3]  
Conti M, 2000, PROG NUCLEIC ACID RE, V63, P1
[4]   Phosphopeptide isomer separation using capillary zone electrophoresis for the study of protein kinases and phosphatases [J].
Gamble, TN ;
Ramachandran, C ;
Bateman, KP .
ANALYTICAL CHEMISTRY, 1999, 71 (16) :3469-3476
[5]   cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular model [J].
Hoffmann, R ;
Wilkinson, IR ;
McCallum, JF ;
Engels, P ;
Houslay, MD .
BIOCHEMICAL JOURNAL, 1998, 333 :139-149
[6]   The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579 [J].
Hoffmann, R ;
Baillie, GS ;
MacKenzie, SJ ;
Yarwood, SJ ;
Houslay, MD .
EMBO JOURNAL, 1999, 18 (04) :893-903
[7]  
Houslay MD, 1998, ADV PHARMACOL, V44, P225, DOI 10.1016/S1054-3589(08)60128-3
[8]  
Jacobitz S, 1996, MOL PHARMACOL, V50, P891
[9]   Conformational difference between PDE4 apoenzyme and holoenzyme [J].
Laliberté, F ;
Han, YX ;
Govindarajan, A ;
Giroux, A ;
Liu, S ;
Bobechko, B ;
Lario, P ;
Bartlett, A ;
Gorseth, E ;
Gresser, M ;
Huang, Z .
BIOCHEMISTRY, 2000, 39 (21) :6449-6458
[10]   Phosphorylation of a cAMP-specific phosphodiesterase (HSPDE4B2B) by mitogen-activated protein kinase [J].
Lenhard, JM ;
Kassel, DB ;
Rocque, WJ ;
Hamacher, L ;
Holmes, WD ;
Patel, I ;
Hoffman, C ;
Luther, M .
BIOCHEMICAL JOURNAL, 1996, 316 :751-758